Morgan Dempsey Capital Management LLC Has $4.38 Million Holdings in Procter & Gamble Company (The) $PG

Morgan Dempsey Capital Management LLC lessened its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 1.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,464 shares of the company’s stock after selling 495 shares during the quarter. Procter & Gamble makes up 1.8% of Morgan Dempsey Capital Management LLC’s holdings, making the stock its 29th biggest position. Morgan Dempsey Capital Management LLC’s holdings in Procter & Gamble were worth $4,376,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC raised its stake in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter worth $1,954,941,000. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. increased its position in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC increased its position in Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after buying an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity

In other news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. The trade was a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

PG has been the topic of several recent research reports. BNP Paribas reiterated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. BNP Paribas Exane lowered their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Wells Fargo & Company decreased their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, Berenberg Bank raised their price target on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $172.21.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Performance

NYSE:PG opened at $151.53 on Friday. The stock’s 50-day simple moving average is $154.92 and its 200 day simple moving average is $158.77. The firm has a market capitalization of $354.66 billion, a PE ratio of 23.28, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble’s revenue was up 1.7% compared to the same quarter last year. During the same period last year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.98%.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.